menu
BRAF Mutation Testing in Melanoma - NeoGenomics Laboratories
BRAF Mutation Testing in Melanoma - NeoGenomics Laboratories
NeoGenomics BRAF Mutation Analysis in Melanoma provides comprehensive analysis of the critical region of BRAF. Use of aspirin in colorectal cancer has previously been associated with favorable outcome. In a current study in the New England Journal of Medicine, Liao et al. report that 5-year cancer-related mortality was reduced by about 80% with regular use of aspirin when patients’ tumors had mutations in the PIK3CA gene. NeoGenomics Laboratories is a specialized cancer diagnostics reference laboratory with four labs in the United States.